SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001387131-16-004111
Filing Date
2016-02-09
Accepted
2016-02-09 17:12:08
Documents
49
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ohrp-10q_123115.htm 10-Q 323771
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex31-1.htm EX-31.1 11814
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex31-2.htm EX-31.2 12279
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex32-1.htm EX-32.1 5787
5 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex32-2.htm EX-32.2 5629
  Complete submission text file 0001387131-16-004111.txt   1671488

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ohrp-20151231.xml EX-101.INS 170171
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ohrp-20151231.xsd EX-101.SCH 23498
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ohrp-20151231_cal.xml EX-101.CAL 35850
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ohrp-20151231_def.xml EX-101.DEF 56565
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ohrp-20151231_lab.xml EX-101.LAB 202061
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ohrp-20151231_pre.xml EX-101.PRE 140180
Mailing Address 800 THIRD AVENUE 11TH FLOOR NEW YORK NY 10022
Business Address 800 THIRD AVENUE 11TH FLOOR NEW YORK NY 10022 (212) 682-8452
Ohr Pharmaceutical Inc (Filer) CIK: 0001173281 (see all company filings)

IRS No.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-35963 | Film No.: 161400955
SIC: 2834 Pharmaceutical Preparations